Farther Finance Advisors, LLC Context Therapeutics Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,500 shares of CNTX stock, worth $1,739. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$1,739% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
43Shares Held
76.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$17.1 Million2.58% of portfolio
-
Avidity Partners Management LP Dallas, TX8.98MShares$10.4 Million4.49% of portfolio
-
Nextech Invest Ag7.42MShares$8.61 Million1.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$8.61 Million0.23% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$8.61 Million1.09% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $18.5M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...